Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, July 21, 2014

In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.

Pictured: Gabriela Chiosis
Finding
By Celia Gittelson, BA  |  Thursday, July 17, 2014

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Slideshow
By Jennifer Bassett, MA, Senior Managing Editor & Content Strategist  |  Wednesday, July 16, 2014

Memorial Sloan Kettering celebrates 130 years of tremendous progress in our quest to eradicate cancer.

Pictured: William Tap
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, July 14, 2014

In this Q&A, medical oncologist William Tap describes Memorial Sloan Kettering’s expertise in providing cutting-edge treatment for people with different types of soft tissue sarcoma.

Pictured: Gum ball machines
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, July 2, 2014

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.

Pictured: Serge Lyashchenko
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, June 27, 2014

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

Pictured: Christine Iacobuzio-Donahue, Eileen O’Reilly, Steven Leach, and Peter Allen
Announcement
By Jim Stallard, MA, Writer/Editor  |  Thursday, June 26, 2014

Our new David M. Rubenstein Center for Pancreatic Cancer Research is an ambitious initiative to solve a difficult and complex disease.

Pictured: Michael Berger
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, June 12, 2014

A powerful diagnostic test, MSK-IMPACT™ gives our doctors an unparalleled amount of information about individual people’s cancers to guide their treatment.

Pictured: Activated macrophage
In the Lab
By Jennifer Bell, PhD  |  Thursday, June 5, 2014

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: 2014 Graduates
Event
By Julie Grisham, MS, Science Writer/Editor  |  Friday, May 23, 2014

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 20, 2014

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.